A study protocol for Project I-Test : a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs
© 2023. BioMed Central Ltd., part of Springer Nature..
BACKGROUND: People with substance use disorders are vulnerable to acquiring HIV. Testing is fundamental to diagnosis, treatment, and prevention; however, in the past decade, there has been a decline in the number of substance use disorder (SUD) treatment programs offering on-site HIV testing. Fewer than half of SUDs in the USA offer on-site HIV testing. In addition, nearly a quarter of newly diagnosed cases have AIDS at the time of diagnosis. Lack of testing is one of the main reasons that annual HIV incidences have remained constant over time. Integration of HIV testing with testing for HCV, an infection prevalent among persons vulnerable to HIV infection, and in settings where they receive health services, including opioid treatment programs (OTPs), is of great public health importance.
METHODS/DESIGN: In this 3-arm cluster-RCT of opioid use disorders treatment programs, we test the effect of two evidence-based "practice coaching" (PC) interventions on the provision and sustained implementation of on-site HIV testing, on-site HIV/HCV testing, and linkage to care. Using the National Survey of Substance Abuse Treatment Services data available from SAMHSA, 51 sites are randomly assigned to one of the three conditions: practice coach facilitated structured conversations around implementing change, with provision of resources and documents to support the implementation of (1) HIV testing only, or (2) HIV/HCV testing, and (3) a control condition that provides a package with information only. We collect quantitative (e.g., HIV and HCV testing at 6-month-long intervals) and qualitative site data near the time of randomization, and again approximately 7-12 months after randomization.
DISCUSSION: Innovative and comprehensive approaches that facilitate and promote the adoption and sustainability of HIV and HCV testing in opioid treatment programs are important for addressing and reducing HIV and HCV infection rates. This study is one of the first to test organizational approaches (practice coaching) to increase HIV and HIV/HCV testing and linkage to care among individuals receiving treatment for opioid use disorder. The study may provide valuable insight and knowledge on the multiple levels of intervention that, if integrated, may better position OTPs to improve and sustain testing practices and improve population health.
TRIAL REGISTRATION: ClinicalTrials.gov NCT03135886. Registered on 2 May 2017.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Trials - 24(2023), 1 vom: 26. Sept., Seite 609 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Frimpong, Jemima A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.09.2023 Date Revised 21.11.2023 published: Electronic ClinicalTrials.gov: NCT03135886 UpdateOf: Res Sq. 2023 Jun 28;:. - PMID 37461594 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13063-023-07602-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362460116 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362460116 | ||
| 003 | DE-627 | ||
| 005 | 20231226091305.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13063-023-07602-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1208.xml |
| 035 | |a (DE-627)NLM362460116 | ||
| 035 | |a (NLM)37749635 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Frimpong, Jemima A |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A study protocol for Project I-Test |b a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.09.2023 | ||
| 500 | |a Date Revised 21.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT03135886 | ||
| 500 | |a UpdateOf: Res Sq. 2023 Jun 28;:. - PMID 37461594 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. BioMed Central Ltd., part of Springer Nature. | ||
| 520 | |a BACKGROUND: People with substance use disorders are vulnerable to acquiring HIV. Testing is fundamental to diagnosis, treatment, and prevention; however, in the past decade, there has been a decline in the number of substance use disorder (SUD) treatment programs offering on-site HIV testing. Fewer than half of SUDs in the USA offer on-site HIV testing. In addition, nearly a quarter of newly diagnosed cases have AIDS at the time of diagnosis. Lack of testing is one of the main reasons that annual HIV incidences have remained constant over time. Integration of HIV testing with testing for HCV, an infection prevalent among persons vulnerable to HIV infection, and in settings where they receive health services, including opioid treatment programs (OTPs), is of great public health importance | ||
| 520 | |a METHODS/DESIGN: In this 3-arm cluster-RCT of opioid use disorders treatment programs, we test the effect of two evidence-based "practice coaching" (PC) interventions on the provision and sustained implementation of on-site HIV testing, on-site HIV/HCV testing, and linkage to care. Using the National Survey of Substance Abuse Treatment Services data available from SAMHSA, 51 sites are randomly assigned to one of the three conditions: practice coach facilitated structured conversations around implementing change, with provision of resources and documents to support the implementation of (1) HIV testing only, or (2) HIV/HCV testing, and (3) a control condition that provides a package with information only. We collect quantitative (e.g., HIV and HCV testing at 6-month-long intervals) and qualitative site data near the time of randomization, and again approximately 7-12 months after randomization | ||
| 520 | |a DISCUSSION: Innovative and comprehensive approaches that facilitate and promote the adoption and sustainability of HIV and HCV testing in opioid treatment programs are important for addressing and reducing HIV and HCV infection rates. This study is one of the first to test organizational approaches (practice coaching) to increase HIV and HIV/HCV testing and linkage to care among individuals receiving treatment for opioid use disorder. The study may provide valuable insight and knowledge on the multiple levels of intervention that, if integrated, may better position OTPs to improve and sustain testing practices and improve population health | ||
| 520 | |a TRIAL REGISTRATION: ClinicalTrials.gov NCT03135886. Registered on 2 May 2017 | ||
| 650 | 4 | |a Clinical Trial Protocol | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cluster randomized controlled trial | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a Hepatitis C virus | |
| 650 | 4 | |a Opioid treatment program | |
| 650 | 4 | |a Organizational change | |
| 650 | 4 | |a Practice coaching | |
| 650 | 4 | |a Substance use disorder treatment | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 700 | 1 | |a Parish, Carrigan L |e verfasserin |4 aut | |
| 700 | 1 | |a Feaster, Daniel J |e verfasserin |4 aut | |
| 700 | 1 | |a Gooden, Lauren K |e verfasserin |4 aut | |
| 700 | 1 | |a Nelson, Mindy C |e verfasserin |4 aut | |
| 700 | 1 | |a Matheson, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Siegel, Karolynn |e verfasserin |4 aut | |
| 700 | 1 | |a Haynes, Louise |e verfasserin |4 aut | |
| 700 | 1 | |a Linas, Benjamin P |e verfasserin |4 aut | |
| 700 | 1 | |a Assoumou, Sabrina A |e verfasserin |4 aut | |
| 700 | 1 | |a Tross, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Kyle, Tiffany |e verfasserin |4 aut | |
| 700 | 1 | |a Liguori, Terri K |e verfasserin |4 aut | |
| 700 | 1 | |a Toussaint, Oliene |e verfasserin |4 aut | |
| 700 | 1 | |a Annane, Debra |e verfasserin |4 aut | |
| 700 | 1 | |a Metsch, Lisa R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trials |d 2006 |g 24(2023), 1 vom: 26. Sept., Seite 609 |w (DE-627)NLM161320430 |x 1745-6215 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:26 |g month:09 |g pages:609 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13063-023-07602-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 1 |b 26 |c 09 |h 609 | ||